Trading Ideas
Do You Like UnitedHealth Group Incorporated (NYSE:UNH) At This P/E Ratio?
Today, we’ll introduce the concept of the P/E ratio for those who are learning about investing. We’ll show how you can… …read more […]
Month: January 2020
Trading Ideas
Top Financial Blogger: These 3 Stocks Can Rip Higher in 2020
David Alton Clark’s reputation as one of the best stock pickers in the game precedes him. Based on the blogger’s track record, he has rightfully earned this reputation. According to TipRanks, a fintech company that tracks and measures the performance of financial experts, Clark’s stock picks see a return of 25.7%, on average. Not to mention his success rate, the number of profitable recommendations measured over one year, comes in at 70%. So, it makes sense, then, that the five-star blogger scores the second spot on TipRanks’ ranking of the Top 25 Bloggers.Highlighting the current economic landscape, Clark advises against …read more […]
Trading Ideas
Business News
New Boeing chief executive: planemaker can be ‘much better’
Boeing Co’s new chief executive, David Calhoun, assumed the job on Monday as the U.S. planemaker battles to recover from two fatal crashes of 737 MAX planes that killed 346 people in five months and led to the model’s worldwide grounding in March.
Trading Ideas
Is MicroStrategy Incorporated's (NASDAQ:MSTR) CEO Pay Fair?
In 1989 Michael Saylor was appointed CEO of MicroStrategy Incorporated (NASDAQ:MSTR). This report will, first, examine… …read more […]
Business News
Wall Street nears record high on trade, earnings optimism
U.S. stock indexes rose to near all-time high on Monday on optimism about the imminent signing of a preliminary U.S.-China trade deal as well as the start of the fourth-quarter corporate earnings season.
Trading Ideas
How the “Master Narrative” Undermines Investors
Academia, Hollywood and the mainstream media would have you believe that the world’s going to hell in a handbasket. But can you really believe that?
Today, Alexander Green explains how this “Master Narrative” undermines investors and hinders their journey toward a rich life.
Editor’s Note: In today’s article, Alexander Green explains the “Master Narrative” and how it can undermine investors. Read on to learn why you shouldn’t buy what the mainstream media, Hollywood and academia are selling, then stay tuned for Alex’s newest initiative launching January 18.
We couldn’t be more excited about his new project and what it means for investors like …read more […]
Trading Ideas
Should Morgan Stanley (NYSE:MS) Be Disappointed With Their 50% Profit?
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet… …read more […]
Trading Ideas
Business News
Banks lobby Aramco for incentive fee after slim IPO pickings: sources
Global banks who worked on Saudi Aramco’s record initial public offering are pushing for an additional “incentive fee”, three sources familiar with the matter said, as they try to boost relatively low earnings from the deal.
Trading Ideas
Trading Ideas
Tesla stock surges after analyst Oppenheimer raises price target
Tesla stock topped $500 per share after Oppenheimer raised price target to $612 a share. Yahoo Finance’s Julie Hyman, Adam Shapiro, Akiko Fujita and Liz Young BNY Mellon Investment Management Director of Market Strategy discuss. …read more […]
Trading Ideas
3 Canadian CBD Players Coming to America; Here’s What You Need to Know
One major catalyst for the U.S. cannabis market is cannabinoid or CBD sales. The passage of the 2018 Agriculture Improvement Act (farm bill) legalized hemp production setting the market up for a strong sales ramp.Hemp contains less than 0.3% of tetrahydrocannabinol (THC), whereas marijuana contains up to 30% of the psychoactive compound. CBD is increasingly presumed to contain properties for wellness and pain management increasing the attractiveness of hemp-infused CBD products, but the U.S. FDA has other thoughts.The FDA has questioned the lack of safety research on CBD products and placed into question the approval of edibles. In addition, CBD …read more […]
Business News
Citi’s corporate banking arm aims to pick up steam as market cools down
When Citigroup Inc combined businesses that cater to big companies in 2018, management wanted dealmakers, traders and traditional corporate bankers to combine forces and propel Citi toward the top of Wall Street market-share rankings.
Healthcare
CytoDyn (OTC: CYDY) Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab for the Treatment of Metastatic Triple-Negative Breast Cancer
VANCOUVER, Washington, Jan. 13, 2020 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the […]